ProQR Therapeutics (PRQR) Income from Non-Controlling Interests (2017 - 2025)
ProQR Therapeutics (PRQR) reported Income from Non-Controlling Interests of -$12.89 million for the quarter ended Sep 30, 2025, compared with -$9.32 million a year earlier.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Income from Non-Controlling Interests (2017 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, ProQR Therapeutics' Income from Non-Controlling Interests came in at -$47.76 million; for the year ended Dec 31, 2023, it was $415,380, up 79.1% from the prior year.
- By year, Income from Non-Controlling Interests came in at $231,870 in the year ended Dec 31, 2022, -$69,820 in the year ended Dec 31, 2021, -$55,947 in the year ended Dec 31, 2020 and -$297,901 in the year ended Dec 31, 2019.
- Five-year quarterly Income from Non-Controlling Interests spans a low of -$14.56 million in the quarter ended Jun 30, 2025 and a high of $315,691 in the quarter ended Sep 30, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | ProQR Therapeutics | 171.74 Mn | -291.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -12.89 Mn |
| Jun 30, 2025 | -14.56 Mn |
| Mar 31, 2025 | -10.99 Mn |
| Sep 30, 2024 | -9.32 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -8.11 Mn |
| Sep 30, 2023 | 315,691.24 |
| Jun 30, 2023 | 17,422.79 |
| Mar 31, 2023 | 83,720.66 |
| Dec 31, 2022 | -3,060.74 |
| Sep 30, 2022 | 14,115.84 |
| Jun 30, 2022 | 231,551.30 |
| Mar 31, 2022 | -8,978.70 |
| Dec 31, 2021 | -21,735.45 |
| Sep 30, 2021 | -25,944.32 |
| Jun 30, 2021 | -8,429.90 |
| Mar 31, 2021 | -13,268.60 |
| Dec 31, 2020 | -13,115.19 |
| Sep 30, 2020 | -9,344.62 |
| Jun 30, 2020 | -7,710.22 |
API Access
ProQR Therapeutics Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();